ARCHIVES

Guideline Revisions or Outstanding Investigator Grant Still Controversial

This article is from The Cancer Letter archive.

Vol. 09 No. 47 | December 9, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: House Budget Committee Proposes 5% Cut To NIH In FY96; Steady Reductions Expected

March 24, 1995

FDA Employee Inspired to Compose an Anthem for the Agency.

August 4, 2006

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977